Total Payments
$10,751
2024 Payments
$1,280
Companies
34
Transactions
390
Medicare Patients
10,276
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$8,291 (77.1%)
Other$1,750 (16.3%)
Travel$710.10 (6.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,291 | 382 | 77.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,750 | 1 | 16.3% |
| Travel and Lodging | $710.10 | 7 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,357 | 106 | $0 (2024) |
| PFIZER INC. | $1,844 | 14 | $0 (2020) |
| Boston Scientific Corporation | $1,200 | 51 | $0 (2022) |
| Abbott Laboratories | $918.06 | 16 | $0 (2023) |
| Medtronic USA, Inc. | $842.22 | 36 | $0 (2020) |
| Nevro Corp. | $625.01 | 25 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $344.16 | 25 | $0 (2024) |
| Electronic Waveform Lab, Inc. | $232.52 | 26 | $0 (2024) |
| Averitas Pharma Inc. | $214.28 | 15 | $0 (2024) |
| Purdue Pharma L.P. | $184.00 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,280 | 51 | Medtronic, Inc. ($966.16) |
| 2023 | $1,941 | 74 | Medtronic, Inc. ($1,412) |
| 2022 | $1,736 | 54 | Abbott Laboratories ($811.69) |
| 2021 | $781.20 | 34 | Medtronic, Inc. ($390.29) |
| 2020 | $402.78 | 17 | Medtronic USA, Inc. ($144.38) |
| 2019 | $781.46 | 56 | Boston Scientific Corporation ($257.42) |
| 2018 | $731.64 | 46 | Medtronic USA, Inc. ($400.51) |
| 2017 | $3,097 | 58 | PFIZER INC. ($1,807) |
All Payment Transactions
390 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $60.95 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/08/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $37.99 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/06/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/02/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Analgesic | ||||||
| 11/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/23/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/22/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $65.73 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/22/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $10.87 | General |
| Category: Opioid Analgesic | ||||||
| 09/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $39.10 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/16/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $43.54 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/28/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $3.68 | General |
| Category: Opioid Analgesic | ||||||
| 08/12/2024 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Antibacterial Mesh | ||||||
| 07/26/2024 | Medtronic, Inc. | VECTRIS SURESCAN (Device) | Food and Beverage | In-kind items and services | $53.03 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $81.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $81.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.99 | General |
| Category: Opioid Analgesic | ||||||
| 07/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: Opioid Analgesic | ||||||
| 06/27/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/18/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Analgesic | ||||||
| 06/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.70 | General |
| Category: Opioid Analgesic | ||||||
| 06/05/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,531 | 16,192 | $1.6M | $316,714 |
| 2022 | 20 | 2,520 | 26,104 | $1.4M | $324,672 |
| 2021 | 19 | 2,536 | 24,003 | $1.6M | $374,869 |
| 2020 | 25 | 2,689 | 21,286 | $1.6M | $354,844 |
Total Patients
10,276
Total Services
87,585
Medicare Billing
$1.4M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 246 | 395 | $505,942 | $88,527 | 17.5% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 16 | 30 | $240,230 | $39,990 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 346 | 644 | $142,144 | $39,448 | 27.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 145 | 244 | $191,981 | $34,189 | 17.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 67 | 118 | $106,740 | $22,783 | 21.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 59 | 89 | $44,220 | $17,335 | 39.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 106 | 152 | $42,814 | $12,548 | 29.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 82 | 112 | $43,639 | $9,638 | 22.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 28 | 46 | $41,272 | $7,640 | 18.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 99 | 144 | $34,714 | $7,037 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $23,981 | $6,900 | 28.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 13 | 17 | $26,642 | $6,415 | 24.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 60 | 91 | $9,494 | $5,542 | 58.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 38 | 58 | $25,110 | $4,769 | 19.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 253 | 566 | $5,660 | $3,276 | 57.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 12 | 18 | $15,694 | $3,258 | 20.8% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 19 | 19 | $11,021 | $1,708 | 15.5% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 11 | 15 | $6,625 | $1,454 | 21.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 13 | 18 | $5,907 | $1,240 | 21.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 78 | 1,009 | $2,422 | $844.52 | 34.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 279 | 8,175 | $32,700 | $792.88 | 2.4% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 419 | 2,272 | $1,522 | $762.51 | 50.1% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 43 | 1,861 | $2,252 | $450.81 | 20.0% |
| 72080 | X-ray of middle and lower spine, 2 views | Office | 2023 | 11 | 11 | $652.52 | $167.31 | 25.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 250 | 533 | $617,316 | $119,197 | 19.3% |
About Dr. William Robinson, MD
Dr. William Robinson, MD is a Pain Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902003361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Robinson, MD has received a total of $10,751 in payments from pharmaceutical and medical device companies, with $1,280 received in 2024. These payments were reported across 390 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,291).
As a Medicare-enrolled provider, Robinson has provided services to 10,276 Medicare beneficiaries, totaling 87,585 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Physical Medicine & Rehabilitation
- Location Hickory, NC
- Active Since 06/29/2007
- Last Updated 02/17/2022
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1902003361
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $1,884
- LYRICA (Drug) $1,811
- PROCLAIM (Device) $811.69
- VANTA ADAPTIVESTIM (Device) $663.23
- Senza Spinal Cord Stimulation System (Device) $491.25
- GENERAL - PAIN MANAGEMENT (Device) $456.96
- INTELLIS (Device) $448.34
- ADAPTIVESTIM (Device) $373.38
- SPECTRA WAVEWRITER (Device) $299.07
- XTAMPZA (Drug) $293.46
- QUTENZA (Drug) $214.28
- ACCURIAN (Device) $187.32
- GENERAL PAIN MANAGEMENT (Device) $174.07
- Vanta (Device) $145.54
- RESTORE (Device) $134.93
- SPECTRA SYSTEM (Device) $122.31
- ZTLido (Drug) $121.85
- Qutenza (Drug) $98.75
- PAINTEQ (Device) $91.05
- VECTRIS SURESCAN (Device) $88.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.